Regular follow-up appointments help us track your progress and address any concerns you may have
It may take time to see changes, especially if a washout period is needed. Comparing weight loss results Tirzepatide shows significantly better weight loss results in clinical studies: In a large study of over 18,000 patients, those taking tirzepatide lost about 15.3% of their body weight in one year, compared to 8.3% with semaglutide
Find enjoyable physical activities to make exercise a sustainable and rewarding part of your routine
Always keep your healthcare provider in the loop for tailored advice that suits your specific needs
This series of phase 3, randomised, double-blind, placebo-controlled clinical trials involved more than 25,000 individuals with overweight or obesity and has extensively demonstrated the efficacy of once-weekly subcutaneous semaglutide 2.4 mg in promoting weight loss [13, 3846]